We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PYCR
2101
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $3.34M | ﹤0.01% |
113,027
-3,811
| -3% | -$110K |
|
2102
Joby Aviation
JOBY
$8.55B
| $3.32M | ﹤0.01% |
729,951
-21,274
| -3% | -$117K |
|
|
CHCT
2103
Community Healthcare Trust
CHCT
$454M
| $3.32M | ﹤0.01% |
101,321
-4,285
| -4% | -$158K |
|
2104
HNI Corp
HNI
$3.59B
| $3.32M | ﹤0.01% |
125,184
-3,958
| -3% | -$131K |
|
2105
Ingles Markets
IMKTA
$1.67B
| $3.31M | ﹤0.01% |
41,790
-7,501
| -15% | -$682K |
|
|
HCCI
2106
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $3.31M | ﹤0.01% |
111,845
+16,443
| +17% | +$514K |
|
|
SRNE
2107
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $3.3M | ﹤0.01% |
2,103,980
+556,799
| +36% | +$1.26M |
|
|
CIO
2108
DELISTED
City Office REIT
CIO
| $3.29M | ﹤0.01% |
330,067
-3,027
| -0.9% | -$37.3K |
|
|
CBL
2109
CBL Properties
CBL
$1.75B
| $3.27M | ﹤0.01% |
114,509
+21,329
| +23% | +$609K |
|
|
BAND
2110
Bandwidth Inc
BAND
$1.61B
| $3.25M | ﹤0.01% |
272,812
-52,696
| -16% | -$866K |
|
|
INVX
2111
Innovex International
INVX
$1.97B
| $3.25M | ﹤0.01% |
166,247
-3,951
| -2% | -$91.6K |
|
2112
Sonic Automotive
SAH
$2.61B
| $3.24M | ﹤0.01% |
74,893
-2,577
| -3% | -$117K |
|
2113
PC Connection
CNXN
$2.12B
| $3.22M | ﹤0.01% |
71,333
-877
| -1% | -$41.4K |
|
2114
The RMR Group
RMR
$332M
| $3.21M | ﹤0.01% |
135,694
+2,426
| +2% | +$66.1K |
|
2115
Warby Parker
WRBY
$3.27B
| $3.21M | ﹤0.01% |
240,991
-4,077
| -2% | -$54.3K |
|
2116
Enerpac Tool Group
EPAC
$1.93B
| $3.21M | ﹤0.01% |
180,252
-9,263
| -5% | -$180K |
|
2117
Spectrum Brands
SPB
$2.07B
| $3.21M | ﹤0.01% |
82,221
-391,714
| -83% | -$25.3M |
|
2118
Agilysys
AGYS
$3.06B
| $3.21M | ﹤0.01% |
57,934
-1,067
| -2% | -$53.8K |
|
2119
Amerant Bancorp
AMTB
$1.13B
| $3.19M | ﹤0.01% |
128,562
-3,419
| -3% | -$93.1K |
|
2120
Clearwater Paper
CLW
$376M
| $3.19M | ﹤0.01% |
84,901
+18,509
| +28% | +$733K |
|
2121
Relmada Therapeutics
RLMD
$527M
| $3.19M | ﹤0.01% |
86,109
-672
| -0.8% | -$18.6K |
|
2122
Adaptive Biotechnologies
ADPT
$3.97B
| $3.19M | ﹤0.01% |
447,451
+12,861
| +3% | +$121K |
|
2123
Energy Transfer Partners
ET
$69.3B
| $3.18M | ﹤0.01% |
288,468
-17,416
| -6% | -$194K |
|
2124
Alector
ALEC
$199M
| $3.18M | ﹤0.01% |
335,849
+58,708
| +21% | +$635K |
|
2125
Qfin Holdings
QFIN
$1.61B
| $3.16M | ﹤0.01% |
246,800
+54,300
| +28% | +$790K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.